Following new JCVI recommendations announced earlier this week, we have updated our information and guidance article about lupus and COVID-19 vaccination.
lupusuk.org.uk/covid19-vacc...
The JCVI are recommending that people with "severe immunosuppression" should be invited for a third COVID-19 vaccine dose to achieve similar levels of protection compared to the broader population.
The British Society for Rheumatology has suggested that nearly all rheumatology patients (aside from those solely on hydroxychloroquine or sulfasalazine), should receive a third dose.